In This Section

Spotlight on Clinical Trials

More than 260 clinical trials were presented at the AACR Annual Meeting 2024. The titles and text of the clinical trial abstracts are available on the online itinerary planner. Detailed summaries of these sessions can be found in AACR Annual Meeting News.

Clinical Trial Abstract Sessions

Beyond Immune Checkpoint Inhibition

Four experts discussed emerging results from clinical trials evaluating novel immunotherapies.

Learn More
Novel Immune Checkpoint Inhibitor Combinations

Four promising studies showcased novel combination therapies for gastroesophageal, colorectal, endometrial, and head and neck cancers.

Learn More
Personalized Cancer Vaccines

The AACR blog reported on two Phase I trials of cancer vaccines presented at the AACR Annual Meeting 2024.

Learn More

ONLINE PUBLICATION OF ABSTRACTS

  • The full text of the Clinical Trial and Late-Breaking Abstracts were posted to the AACR Online Itinerary Planner and the Meeting App on April 5, 2024, except those abstracts that were selected for inclusion in the official AACR press program. Abstracts featured in the official AACR press program were made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.  
  • In previous years, abstracts accepted for presentation at the AACR Annual Meeting were published in an online-only Proceedings supplement to the AACR journal Cancer Research after the conclusion of the meeting. For the AACR Annual Meeting 2024, the Proceedings supplement was published prior to the meeting in two parts. Part 1 of the online Proceedings (regular abstracts) was published on March 22, and Part 2 (clinical trials and late-breaking abstracts) was published on April 5. Revised Proceedings supplements containing the full text of embargoed abstracts as well as any late change will be published in Cancer Research approximately one month after the meeting.